ATE249471T1 - 3'-substuierte nukleosidderivate - Google Patents

3'-substuierte nukleosidderivate

Info

Publication number
ATE249471T1
ATE249471T1 AT95940427T AT95940427T ATE249471T1 AT E249471 T1 ATE249471 T1 AT E249471T1 AT 95940427 T AT95940427 T AT 95940427T AT 95940427 T AT95940427 T AT 95940427T AT E249471 T1 ATE249471 T1 AT E249471T1
Authority
AT
Austria
Prior art keywords
group
chem
ester
living body
substituted
Prior art date
Application number
AT95940427T
Other languages
English (en)
Inventor
Akira Matsuda
Takuma Sasaki
Original Assignee
Taiho Pharmaceutical Co Ltd
Akira Matsuda
Takuma Sasaki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd, Akira Matsuda, Takuma Sasaki filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE249471T1 publication Critical patent/ATE249471T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
AT95940427T 1994-12-13 1995-12-13 3'-substuierte nukleosidderivate ATE249471T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30891294 1994-12-13
JP20864595 1995-08-16
PCT/JP1995/002554 WO1996018636A1 (fr) 1994-12-13 1995-12-13 Derives de nucleoside substitues en 3'

Publications (1)

Publication Number Publication Date
ATE249471T1 true ATE249471T1 (de) 2003-09-15

Family

ID=26516961

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95940427T ATE249471T1 (de) 1994-12-13 1995-12-13 3'-substuierte nukleosidderivate

Country Status (18)

Country Link
US (2) USRE38090E1 (de)
EP (1) EP0747389B1 (de)
JP (1) JP3142874B2 (de)
KR (1) KR0177372B1 (de)
CN (1) CN1195768C (de)
AT (1) ATE249471T1 (de)
AU (1) AU674639B2 (de)
CA (1) CA2182707C (de)
DE (1) DE69531729T2 (de)
DK (1) DK0747389T3 (de)
ES (1) ES2206522T3 (de)
FI (1) FI118967B (de)
HU (1) HU217772B (de)
NO (1) NO305702B1 (de)
NZ (1) NZ297100A (de)
PT (1) PT747389E (de)
RU (1) RU2130029C1 (de)
WO (1) WO1996018636A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69531729T2 (de) * 1994-12-13 2004-08-05 Taiho Pharmaceutical Co. Ltd. 3'-substuierte nukleosidderivate
CA2172471C (en) * 1995-03-29 1999-01-26 Hua Qi Apparatus for and method of simulating ocular optical system
US6235782B1 (en) 1998-11-12 2001-05-22 Rifat Pamukcu Method for treating a patient with neoplasia by treatment with a platinum coordination complex
US6235776B1 (en) 1998-11-12 2001-05-22 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
MY164523A (en) * 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
CN1315862C (zh) 2000-05-26 2007-05-16 艾登尼科斯（开曼）有限公司 处理黄病毒和瘟病毒的方法和组合物
US7138376B2 (en) 2001-09-28 2006-11-21 Idenix Pharmaceuticals, Inc. Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides
US7012100B1 (en) 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
NZ537662A (en) * 2002-06-28 2007-10-26 Idenix Cayman Ltd 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
US7456155B2 (en) 2002-06-28 2008-11-25 Idenix Pharmaceuticals, Inc. 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
AP2005003211A0 (en) * 2002-06-28 2005-03-31 Idenix Cayman Ltd 1'-,2'-and 3'-modified nucleoside derivatives for treating flaviviridae infections.
EP1576138B1 (de) 2002-11-15 2017-02-01 Idenix Pharmaceuticals LLC. 2'-methyl nukleoside in kombination mit interferon und flaviviridae-mutation
KR20050109918A (ko) * 2002-12-12 2005-11-22 이데닉스 (케이만) 리미티드 2'-분지형 뉴클레오시드의 제조 방법
MXPA05008736A (es) * 2003-02-19 2005-10-05 Univ Yale Analogos de nucleosido antivirales y metodos para tratar infecciones virales, especialmente infecciones por vih.
BRPI0512360A (pt) * 2004-06-23 2008-03-11 Idenix Cayman Ltd derivados de 5-aza-7-deazapurina para o tratamento de flaviviridae
JP4516863B2 (ja) * 2005-03-11 2010-08-04 株式会社ケンウッド 音声合成装置、音声合成方法及びプログラム
EP1976382B1 (de) 2005-12-23 2013-04-24 IDENIX Pharmaceuticals, Inc. Verfahren zur herstellung eines synthetischen zwischenprodukts für die herstellung von verzweigten nukleosiden
ATE525386T1 (de) 2006-07-24 2011-10-15 Taiho Pharmaceutical Co Ltd 3'-ethynylcytidinderivat
JP5066737B2 (ja) 2007-04-06 2012-11-07 大鵬薬品工業株式会社 シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤
JP4954004B2 (ja) 2007-08-09 2012-06-13 株式会社バイオダイナミクス研究所 任意の化合物が導入された新規核酸誘導体、及びその製造方法
JP5581200B2 (ja) 2008-03-27 2014-08-27 大鵬薬品工業株式会社 シチジン誘導体及びカルボプラチンを含有する抗腫瘍剤
WO2014033617A1 (en) 2012-08-31 2014-03-06 Novartis Ag 2'-ethynyl nucleoside derivatives for treatment of viral infections
EP3558998A4 (de) * 2016-12-22 2020-06-10 Calithera Biosciences, Inc. Ektonukleotidasehemmer und verfahren zur verwendung davon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3480613A (en) * 1967-07-03 1969-11-25 Merck & Co Inc 2-c or 3-c-alkylribofuranosyl - 1-substituted compounds and the nucleosides thereof
BR6913026D0 (pt) * 1968-10-04 1973-02-22 Esco Corp Guarnicao de reforco amovivel para a colher de uma pa mecanica
DE3924424A1 (de) * 1989-07-24 1991-01-31 Boehringer Mannheim Gmbh Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung
DE4204032A1 (de) * 1992-02-12 1993-08-19 Boehringer Mannheim Gmbh Neue liponucleotide, deren herstellunmg sowie deren verwendung als antivirale arzneimittel
EP0598910A1 (de) * 1992-03-11 1994-06-01 Japan Tobacco Inc. Verfahren zur herstellung von nukleosidderivaten
DE4418690A1 (de) * 1994-05-28 1996-01-11 Boehringer Mannheim Gmbh Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel
US5681940A (en) * 1994-11-02 1997-10-28 Icn Pharmaceuticals Sugar modified nucleosides and oligonucleotides
DE69531729T2 (de) * 1994-12-13 2004-08-05 Taiho Pharmaceutical Co. Ltd. 3'-substuierte nukleosidderivate

Also Published As

Publication number Publication date
CN1195768C (zh) 2005-04-06
DE69531729D1 (de) 2003-10-16
FI963148A (fi) 1996-08-12
EP0747389A1 (de) 1996-12-11
DE69531729T2 (de) 2004-08-05
EP0747389A4 (de) 1998-12-30
EP0747389B1 (de) 2003-09-10
ES2206522T3 (es) 2004-05-16
HUT75227A (en) 1997-04-28
USRE38090E1 (en) 2003-04-22
FI118967B (fi) 2008-05-30
DK0747389T3 (da) 2004-01-26
NO963350L (no) 1996-10-11
US5763418A (en) 1998-06-09
HU217772B (hu) 2000-04-28
KR0177372B1 (ko) 1999-04-01
RU2130029C1 (ru) 1999-05-10
JP3142874B2 (ja) 2001-03-07
NO305702B1 (no) 1999-07-12
KR970701198A (ko) 1997-03-17
WO1996018636A1 (fr) 1996-06-20
NZ297100A (en) 1997-10-24
PT747389E (pt) 2003-12-31
CA2182707C (en) 2000-05-30
NO963350D0 (no) 1996-08-12
CN1140453A (zh) 1997-01-15
AU674639B2 (en) 1997-01-02
AU4188496A (en) 1996-07-03
HU9602214D0 (en) 1996-11-28
FI963148A0 (fi) 1996-08-12

Similar Documents

Publication Publication Date Title
DK0747389T3 (da) 3'-substituerede nukleosidderivater
DK0536936T3 (da) Pyrimidinnukleosidderivater med anti-tumor-aktivitet, deres fremstilling og anvendelse
DK535789A (da) Pyrimidindionderivater, fremgangsmaade til fremstilling heraf og antiarytmika omfattende samme
ES2118069T3 (es) Profarmacos de fosfonatos.
DE69814375T2 (de) Fungizide trifluoromethylalkylamino-triazolopyrimidine-derivate
HK1041828A1 (en) Use of cytidine derivatives for the treatment of leukaemia
NL300247I1 (nl) 2-Halogeen-9-(2-desoxy-2-fluor-bêta-D-arabinofuranosyl)-adeninenucleosiderivaten.
DE69025529D1 (de) Weitere antivirale Pyrimidin-Nukleosiden
HUT62582A (en) Process for producing pyrimidine nucleoside derivatives and pharmaceutical compositions comprising same as active ingredient
DE69001111D1 (de) Antikrebs-zusammensetzung.
YU47802A (sh) Postupci i kompozicije za levovirin
DE3881862T2 (de) Disaccharidderivate.
PT92080A (pt) Processo para a preparacao de novos glicosidos antraciclinicos e de antraciclinonas 4-substituidas intermedias com accao anti-tumoral
ATE38677T1 (de) Derivate von cyanoimidazol-nukleosiden.
ATE72443T1 (de) Glucopyranose-derivate.
ES2037401T3 (es) Procedimiento para preparar derivados de nucleosidos.
DE69331814T2 (de) Salze von Glukopyranosederivate und ihre Zwischenprodukte
ES2164013A1 (es) Glicosidos de n-acetil-6-o-(2,2-bis(hidroximetil)-3-hidroxipropil)-d-glucosamina, procedimiento de obtencion y uso en el tratamiento de tumores cerebrales.
DK0682023T3 (da) Imidazopyridinderivater og fremgangsmåde til fremstilling deraf

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0747389

Country of ref document: EP